NCT01484782

Brief Summary

The purpose of this study is to evaluate the feasibility of utilizing an interactive voice response (IVR) system to supplement hypertension self-management for patients in underdeveloped regions in Mexico and Honduras. Weekly disease assessment calls included hypertension self-management suggestions and support to patients. The impact on patients' blood pressure levels and other secondary outcomes were evaluated.

Trial Health

90
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P50-P75 for not_applicable hypertension

Timeline
Completed

Started May 2011

Shorter than P25 for not_applicable hypertension

Geographic Reach
2 countries

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2011

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2011

Completed
29 days until next milestone

First Submitted

Initial submission to the registry

November 30, 2011

Completed
2 days until next milestone

First Posted

Study publicly available on registry

December 2, 2011

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2012

Completed
Last Updated

April 28, 2015

Status Verified

April 1, 2015

Enrollment Period

6 months

First QC Date

November 30, 2011

Last Update Submit

April 24, 2015

Conditions

Keywords

HypertensionTelephone Care ManagementBlood pressureMedication adherenceInteractive Voice Response (IVR)Cloud computing

Outcome Measures

Primary Outcomes (1)

  • Systolic blood pressure

    6 weeks

Secondary Outcomes (2)

  • Self-reported health status

    6 weeks

  • Medication adherence

    6 weeks

Study Arms (2)

Interactive Voice Response (IVR) calls

EXPERIMENTAL

Weekly automated telephone assessment and behavior change calls focused on blood pressure management. The experimental group will receive a weekly 10-minute automated phone call to their telephone for disease assessment and self-care support for 6 weeks. In-home blood pressure cuffs were provided for measurement of blood pressure throughout the study.

Behavioral: Interactive Voice Response (IVR) automated calls

Usual care

NO INTERVENTION

This group received results of blood pressure readings. PCP referrals. Educational materials about hypertension and self-management. At follow-up, patients received home blood pressure monitoring cuffs.

Interventions

Interactive Voice Response (IVR) is a type of automated telephone call. Weekly automated telephone assessment and behavior change calls focused on blood pressure management will be sent to the experimental group. They will receive a weekly 10-minute automated phone call to their telephone for disease assessment and self-care support for 6 weeks. In-home blood pressure cuffs were provided for measurement of blood pressure throughout the study.

Interactive Voice Response (IVR) calls

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Hypertension (for diabetic patients: systolic blood pressure 130 or greater; for non-diabetic patients: systolic blood pressure 140 or greater)
  • Access to a functional telephone
  • Able to respond to automated telephone calls

You may not qualify if:

  • No access to a functional telephone
  • Diagnosis of cancer with less than a six month life expectancy
  • Severe mental illness as reported by their clinical team

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Yojoa International Medical Center

Santa Cruz de Yojoa, Cortés Department, Honduras

Location

Remedi Diabetes Clinic

Pachuca, Hidalgo, Mexico

Location

MeSH Terms

Conditions

HypertensionMedication Adherence

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular DiseasesPatient CompliancePatient Acceptance of Health CareTreatment Adherence and ComplianceHealth BehaviorBehavior

Study Officials

  • John D Piette, PhD

    University of Michigan

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor, University of Michigan

Study Record Dates

First Submitted

November 30, 2011

First Posted

December 2, 2011

Study Start

May 1, 2011

Primary Completion

November 1, 2011

Study Completion

January 1, 2012

Last Updated

April 28, 2015

Record last verified: 2015-04

Locations